An open-label study of tenofovir in HIV-1 and Hepatitis B virus co-infected individuals.

Abstract

BACKGROUND Tenofovir is a novel nucleotide analogue recommended for use in HIV-1 infected treatment-experienced patients. Recent data suggest an effect on Hepatitis B virus (HBV) replication. We therefore investigated the use of tenofovir in HIV-1 and HBV co-infected individuals. METHODS Twenty HIV-1/HBV co-infected patients with a median of 108 weeks lamivudine experience (range, 0-270 weeks) received tenofovir 245 mg daily in addition to or as part of their combination antiretroviral therapy. Their immunologic parameters and HIV-1 RNA and HBV DNA viral loads were followed over a period of 52 weeks. In addition, their HBV DNA polymerase was sequenced at baseline to measure the frequency of YMDD mutations that are associated with lamivudine resistance. FINDINGS A significant decrease in HBV DNA viral load (4 x log ) and alanine aminotransferase levels was observed. There were no significant overall differences between the lamivudine-experienced (n = 15) and -naive (n = 5) individuals and tenofovir was well tolerated. Five patients (25%) underwent HBe antigen seroconversion during the study period. Out of the 15 lamivudine-experienced individuals, 10 had YMDD mutations and one had YIDD mutations in HBV DNA. INTERPRETATION These results indicate that 52 weeks of tenofovir in addition to antiretroviral therapy is active against HBV, and it appears to overcome lamivudine resistance.

Statistics

02040'04'06'08'10'12'14'16
Citations per Year

135 Citations

Semantic Scholar estimates that this publication has 135 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Nelson2003AnOS, title={An open-label study of tenofovir in HIV-1 and Hepatitis B virus co-infected individuals.}, author={Mark Richard Nelson and Simon D. Portsmouth and Justin Stebbing and Mark G. Atkins and Arlene Barr and Gail V. Matthews and Deenan Pillay and Martin Fisher and Mark Bower and Brian George Gazzard}, journal={AIDS}, year={2003}, volume={17 1}, pages={F7-10} }